Not only is Wegovy extremely effective (people lose about 15% of their body weight in a year), it also appears to have many ...

In the inaugural episode of "Unlocking the Fatty Liver Mistry," Dr. Neeraj Mistry, Chief Medical Officer of the Fatty Liver Foundation, shares crucial insights on the often-overlooked health ...

In addition to their ongoing community work, the team will host a Liver Health Check event in Scunthorpe on January 31. Local ...

Non-alcoholic fatty liver disease (NAFLD) is the physiological manifestation of obesity in the liver. The prevalence of NAFLD has increased from 25.24% in 2015 to 29.38% in 2021, and this condition ...

PNN Greater Noida Uttar Pradesh [India] November 15 School of Medical Sciences and Research SMSR at Sharda Hospital ...

The global fatty liver treatment market, valued at approximately USD 20 Billion in 2022, is anticipated to witness ...

The weight-loss jab Wegovy made its debut on June 4 2021 . It was the first new weight-loss drug to be approved by the US ...

The weight-loss jab Wegovy made its debut on June 4 2021 . It was the first new weight-loss drug to be approved by the US Food and Drug ...

for which there is only one recently approved treatment in the United States and no currently approved treatments in Europe. In 2023, global liver disease medical societies and patient groups ...

Even when patients are aware of the risks, adherence to diet, exercise, and medication remains low—even among those who have ...

UAB researchers have reversed metabolic dysfunction-associated steatohepatitis (MASH) in mouse models. MASH is a severe liver disease associated with obesity and type 2 diabetes that affects more than ...